SMS PHARMACEUTICALS
Back to Income Statement
|
SMS PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹69 Cr | ₹50 Cr | ₹-7.06 Cr | ₹62 Cr | ₹63 Cr |
What is the latest Consolidated Net Profit of SMS PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹69 Cr |
| Mar2024 | ₹50 Cr |
| Mar2023 | ₹-7.06 Cr |
| Mar2022 | ₹62 Cr |
| Mar2021 | ₹63 Cr |
How is Consolidated Net Profit of SMS PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹69 Cr | 38.75 | |
| Mar2024 | ₹50 Cr | Positive | |
| Mar2023 | ₹-7.06 Cr | Negative | |
| Mar2022 | ₹62 Cr | -0.49 | |
| Mar2021 | ₹63 Cr | - | |
Compare Consolidated Net Profit of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,344.6 Cr | -1% | -7.9% | 53.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -1% |
-7.9% |
53.6% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses